An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Kırıkkale University School of Medicine Department of Anaesthesiology and Reanimation, Kırıkkale, Yahşihan, Turkey
Cukurova University, Adana, Turkey
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of
Xijing Hospital, Xi'an, Shaanxi, China
Hospital for Sick Children, Toronto, Ontario, Canada
Jiyoung Yoo, Suweon, Kyunggido, Korea, Republic of
King Abdulaziz University Hospital at King Saud University, Riyadh, Saudi Arabia
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.